Nobel Prize Recognizes Groundbreaking Immune System Research

The Nobel Prize in medical science was granted for transformative findings that clarify how the body's defense network targets harmful infections while sparing the healthy tissues.

Three esteemed scientists—Japan's Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this honor.

The research identified unique "sentinels" within the immune system that remove rogue defense cells that could harming the body.

The discoveries are now paving the way for new therapies for immune disorders and cancer.

These laureates will divide a prize fund worth 11 million SEK.

Decisive Discoveries

"Their work has been essential for understanding how the immune system operates and why we do not all suffer from severe self-attack conditions," commented the chair of the award panel.

The trio's research address a core mystery: How does the immune system protect us from numerous invaders while keeping our own tissues intact?

The body's protection system employs immune cells that search for signs of disease, including viruses and germs it has not met before.

These cells utilize sensors—known as receptors—that are produced by chance in a vast number of combinations.

This provides the defense network the capacity to combat a broad range of invaders, but the unpredictability of the mechanism inevitably produces immune cells that can attack the body.

Security Guards of the Immune System

Scientists previously knew that a portion of these problematic defense cells were destroyed in the thymus—where white blood cells develop.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to neutralize other immune cells that assault the body's own tissues.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

The prize committee stated, "The findings have established a novel area of research and spurred the creation of new therapies, for example for tumors and immune disorders."

In cancer, T-regs prevent the body from fighting the growth, so research are aimed at lowering their numbers.

For autoimmune diseases, experiments are exploring boosting T-reg cells so the organism is no longer under attack. A similar approach could also be useful in reducing the risks of transplanted organ rejection.

Pioneering Studies

Prof Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus removed, leading to autoimmune disease.

He showed that introducing defense cells from other mice could prevent the disease—implying there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in mice and humans that led to the discovery of a gene critical for how regulatory T-cells operate.

"Their pioneering work has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the body's own tissues," commented a leading physiology specialist.

"The work is a striking example of how fundamental biological research can have broad implications for public health."